Regulatory Filings

TSXHLS

Description	Date	Format
News release - English	Nov 29, 2022
News release - English	Nov 14, 2022
News release - English	Nov 10, 2022
News release - English	Nov 7, 2022
News release - English	Oct 27, 2022
News release - English	Oct 3, 2022
News release - English	Sep 15, 2022
News release - English	Sep 8, 2022
News release - English	Aug 11, 2022
News release - English	Aug 2, 2022
News release - English	Jul 28, 2022
News release - English	Jul 25, 2022
News release - English	Jun 22, 2022
News release - English	Jun 17, 2022
News release - English	Jun 15, 2022
News release - English	Jun 1, 2022
News release - English	May 24, 2022
News release - English	May 24, 2022
News release - English	May 5, 2022
News release - English	Apr 28, 2022
News release - English	Apr 26, 2022
News release - English	Apr 25, 2022
News release - English	Mar 17, 2022
News release - English	Mar 14, 2022
News release - English	Jan 12, 2022

SEDAR® is a registered trade-mark of and property of the Alberta Securities Commission

HLS Therapeutics Inc.

HLS provides access to
treatments critical to patients
and their caregivers with the
brand names they trust.

Site Menu

Contact Info

1-647-495-9000

10 Carlson Court, Suite 701
Etobicoke, Ontario, M9W 6L2

U.S. Privacy Policy | Canada Privacy Policy | Terms of Use

WS0004_0